These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1065735)

  • 21. Cushing's syndrome: a ten year experience at Tikur Anbassa Hospital.
    Feleke Y; Abdulkadir J; Johnson O; Munie T
    Ethiop Med J; 1998 Jan; 36(1):19-26. PubMed ID: 10214444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transient disorders observed during injection of triamcinolone acetonide into keloids].
    Mazurkiewicz W
    Przegl Dermatol; 1980; 67(5):623-6. PubMed ID: 7455156
    [No Abstract]   [Full Text] [Related]  

  • 23. Eradication of large auricular keloids by excision, skin grafting, and intradermal injection of triamcinolone acetonide solution. Case report.
    Converse JM; Stallings JO
    Plast Reconstr Surg; 1972 Apr; 49(4):461-3. PubMed ID: 4552358
    [No Abstract]   [Full Text] [Related]  

  • 24. Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars.
    Darougheh A; Asilian A; Shariati F
    Clin Exp Dermatol; 2009 Mar; 34(2):219-23. PubMed ID: 19018794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Keloids treated with topical injections of triamcinolone acetonide (kenalog). Immediate and long-term results.
    Kiil J
    Scand J Plast Reconstr Surg; 1977; 11(2):169-72. PubMed ID: 345427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of corticosteroid injection for trochanter pain syndrome: design of a randomised clinical trial in general practice.
    Brinks A; van Rijn RM; Bohnen AM; Slee GL; Verhaar JA; Koes BW; Bierma-Zeinstra SM
    BMC Musculoskelet Disord; 2007 Sep; 8():95. PubMed ID: 17880718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outbreak of exogenous Cushing's syndrome due to unlicensed medications.
    Azizi F; Jahed A; Hedayati M; Lankarani M; Bejestani HS; Esfahanian F; Beyraghi N; Noroozi A; Kobarfard F
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):921-5. PubMed ID: 18462262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intralesional injection of triamcinolone diacetate in the control of lichen planus.
    Spaulding CR; Friedman JM
    N Y State Dent J; 1979; 45(7):334-7. PubMed ID: 293584
    [No Abstract]   [Full Text] [Related]  

  • 30. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup.
    Friedman TC; Zuckerbraun E; Lee ML; Kabil MS; Shahinian H
    Horm Metab Res; 2007 Jun; 39(6):451-6. PubMed ID: 17578763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategy for Successful Management of Facial Keloid Using Triamcinolone Injection as Adjunct to Surgery.
    Aluko-Olokun B; Olaitan AA
    J Craniofac Surg; 2016 Nov; 27(8):e775-e776. PubMed ID: 28005821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cushing syndrome induced by serial occipital nerve blocks containing corticosteroids.
    Lavin PJ; Workman R
    Headache; 2001 Oct; 41(9):902-4. PubMed ID: 11703480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Keloids.
    Quarles FN; Brody H; Johnson BA; Badreshia S; Vause SE; Brauner G; Breadon JY; Swinehart J
    Dermatol Ther; 2007; 20(3):142-6. PubMed ID: 17803608
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of intravitreal triamcinolone on intraocular pressure.
    Kramar M; Vu L; Whitson JT; He YG
    Curr Med Res Opin; 2007 Jun; 23(6):1253-8. PubMed ID: 17559723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of triamcinolone (acetyl triamcinolone) on keloidal scars].
    Modolin M; Gemperli R; Pigossi N; Lodovici O
    Rev Paul Med; 1984; 102(4):163-5. PubMed ID: 6515262
    [No Abstract]   [Full Text] [Related]  

  • 36. Triamcinolone and keloids.
    Epstein E
    West J Med; 1980 Sep; 133(3):257-8. PubMed ID: 7415179
    [No Abstract]   [Full Text] [Related]  

  • 37. [Iatrogenic Cushing's syndrome caused by an acute overdose of triamcinolone].
    Girre C; Vincens M; Gompel A; Fournier PE
    Therapie; 1987; 42(3):317-8. PubMed ID: 3660326
    [No Abstract]   [Full Text] [Related]  

  • 38. New combination of triamcinolone, 5-Fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars.
    Asilian A; Darougheh A; Shariati F
    Dermatol Surg; 2006 Jul; 32(7):907-15. PubMed ID: 16875473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morbidity from paraspinal depo corticosteroid injections for analgesia: Cushing's syndrome and adrenal suppression.
    Edmonds LC; Vance ML; Hughes JM
    Anesth Analg; 1991 Jun; 72(6):820-2. PubMed ID: 2035867
    [No Abstract]   [Full Text] [Related]  

  • 40. Unusual complications of triamcinolone injected keloids: tissue necrosis and systemic corticosteroid effects.
    Abdel-Fattah AM
    Br J Plast Surg; 1976 Oct; 29(4):283. PubMed ID: 1000110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.